Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D Compared ot Microfracture in the Treatment of Articular Cartilage Defects

NCT01957722 is registered in ClinicalTrials.gov with Aesculap Biologics, LLC as lead sponsor.

NCT NCT01957722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01957722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D Compared ot Microfracture in the Treatment of Articular Cartilage Defects
Lead sponsor
Aesculap Biologics, LLC
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 31, 2013
Completion date
December 31, 2027
Enrollment
233 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

articular cartilage of the femoral condyle between 2-6cm2